Covid-19
-
WHO validates 3rd Chinese Covid vaccine for emergency use
Geneva, May 19 (UNI/Xinhua): The World Health Organization (WHO) validated on Thursday the CONVIDECIA Covid-19 vaccine developed by Chinese developer…
Read More » -
Covaxin, Corbevax get nod for 5-12 years
New Delhi, April 26 (UNI): Bharat Biotech’s Covaxin has been approved for being administered to children between 6 and 12…
Read More » -
WHO calls for caution as Covid restrictions eased in Africa
Brazzaville, Mar 24 (UNI/Xinhua): A World Health Organization (WHO) regional office on Thursday called for caution and consideration of the…
Read More » -
PM urges youngsters in 12-14 age group to get vaccinated
New Delhi, Mar 16 (UNI): As the Covid-19 vaccination for 12-14 age group and precaution dose for those above 60…
Read More » -
China imposes lockdown amid new Covid outbreak
Beijing, Mar 11 (UNI/Xinhua): Authorities in Changchun, capital of northeast China’s Jilin Province, on Friday ordered the closed management of…
Read More » -
WHO sees ‘ceasefire’ opportunity in fighting Covid-19 in Europe
Copenhagen, Feb 3 (UNI/Xinhua): The European region is approaching “a plausible endgame” in its fight against the Covid-19 pandemic while…
Read More » -
Covaxin, Covishield receive regulator nod for conditional market authorisation
New Delhi, Jan 27 (UNI): Two Covid-19 vaccines, Covaxin by Bharat Biotech and Covishield by the Serum Institute of India,…
Read More » -
Covaxin booster dose neutralises Omicron & Delta variants
New Delhi, Jan 12: Bharat Biotech said on Wednesday that Covaxin has the potential to neutralise SARS-CoV-2 variants, including Omicron.…
Read More » -
NCDC plans surprise visits at hospitals to assess severe Covid cases
New Delhi, Jan 10 (UNI): The National Centre for Disease Control (NCDC) will assess the causes of disease severity among…
Read More » -
Massive jump in Andaman Covid-19 cases
Port Blair, Jan 10 (UNI): Andaman and Nicobar Islands has reported as many as 175 new cases of COVID-19, taking…
Read More »